Systematic analysis of cell-type differences in the epithelial secretome reveals insights into the pathogenesis of respiratory syncytial virus-induced lower respiratory tract infections

Journal of Immunology

Volumn 198, Issue 8, 2017, Pages 3345-3364

  Zhao, Yingxin ^a,b   Jamaluddin, Mohammad ^a,b   Zhang, Yueqing ^b   Sun, Hong ^b   Ivanciuc, Teodora ^b   Garofalo, Roberto P ^a,b   Brasier, Allan R ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; THYMIC STROMAL LYMPHOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIOLE CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; EPITHELIAL SECRETOME; EPITHELIUM CELL; EXOSOME; HUMAN; HUMAN CELL; LOWER RESPIRATORY TRACT INFECTION; MACROPHAGE; MOUSE; NONHUMAN; POLARIZATION; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH2 CELL; TRACHEA; VALIDATION PROCESS; VIRUS PATHOGENESIS; AIRWAY REMODELING; BRONCHIOLE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; METABOLISM; PROCEDURES; PROTEOMICS; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTION;

AIRWAY REMODELING; BRONCHIOLES; CELLS, CULTURED; HUMANS; PROTEOMICS; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; TRACHEA;

EID: 85017343705     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601291     Document Type: Article

References (81)

1. Hall, C. B., G. A. Weinberg, M. K. Iwane, A. K. Blumkin, K. M. Edwards, M. A. Staat, P. Auinger, M. R. Griffin, K. A. Poehling, D. Erdman, et al. 2009. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360: 588-598.
2. Easton, A. J., J. B. Domachowske, and H. F. Rosenberg. 2004. Animal pneumoviruses: molecular genetics and pathogenesis. Clin. Microbiol. Rev. 17: 390-412.
3. Hall, C. B., G. A. Weinberg, A. K. Blumkin, K. M. Edwards, M. A. Staat, A. F. Schultz, K. A. Poehling, P. G. Szilagyi, M. R. Griffin, J. V. Williams, et al. 2013. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics 132: e341-e348.
4. Collins, P. L., and B. S. Graham. 2008. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82: 2040-2055.
5. Zorc, J. J., and C. B. Hall. 2010. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 125: 342-349.
6. Moore, M. L., K. L. Stokes, and T. V. Hartert. 2013. The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses. Curr. Opin. Immunol. 25: 761-768.
7. Hall, C. B. 2001. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344: 1917-1928.
8. Shay, D. K., R. C. Holman, R. D. Newman, L. L. Liu, J. W. Stout, and L. J. Anderson. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282: 1440-1446.
9. Nair, H., D. J. Nokes, B. D. Gessner, M. Dherani, S. A. Madhi, R. J. Singleton, K. L. O'Brien, A. Roca, P. F. Wright, N. Bruce, et al. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet 375: 1545-1555.
10. Sigurs, N., P. M. Gustafsson, R. Bjarnason, F. Lundberg, S. Schmidt, F. Sigurbergsson, and B. Kjellman. 2005. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171: 137-141.
11. Richardson, L. S., R. B. Belshe, D. L. Sly, W. T. London, D. A. Prevar, E. Camargo, and R. M. Chanock. 1978. Experimental respiratory syncytial virus pneumonia in cebus monkeys. J. Med. Virol. 2: 45-59.
12. Liesman, R. M., U. J. Buchholz, C. L. Luongo, L. Yang, A. D. Proia, J. P. DeVincenzo, P. L. Collins, and R. J. Pickles. 2014. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J. Clin. Invest. 124: 2219-2233.
13. Garofalo, R. P., and H. Haeberle. 2000. Epithelial regulation of innate immunity to respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 23: 581-585.
14. Tian, B., Y. Zhang, B. A. Luxon, R. P. Garofalo, A. Casola, M. Sinha, and A. R. Brasier. 2002. Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. J. Virol. 76: 6800-6814.
15. Zhang, Y., B. A. Luxon, A. Casola, R. P. Garofalo, M. Jamaluddin, and A. R. Brasier. 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 75: 9044-9058.
16. Bennett, B. L., R. P. Garofalo, S. G. Cron, Y. M. Hosakote, R. L. Atmar, C. G. Macias, and P. A. Piedra. 2007. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J. Infect. Dis. 195: 1532-1540.
17. Holt, P. G., D. H. Strickland, M. E. Wikström, and F. L. Jahnsen. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8: 142-152.
18. Choudhary, S., I. Boldogh, and A. R. Brasier. 2016. Inside-out signaling pathways from nuclear reactive oxygen species control pulmonary innate immunity. J. Innate Immun. 8: 143-155.
19. Whitsett, J. A., and T. Alenghat. 2015. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat. Immunol. 16: 27-35.
20. Olzewska, B., A. Casola, T. Saito, R. Alam, S. Crowe, F. Mei, P. L. Ogra, and R. Garofalo. 1998. Cell-specific expression of RANTES, MCP-1, and MIP-1a by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72: 4756-4764.
21. Welliver, T. P., R. P. Garofalo, Y. Hosakote, K. H. Hintz, L. Avendano, K. Sanchez, L. Velozo, H. Jafri, S. Chavez-Bueno, P. L. Ogra, et al. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195: 1126-1136.
22. Ramirez, R. D., S. Sheridan, L. Girard, M. Sato, Y. Kim, J. Pollack, M. Peyton, Y. Zou, J. M. Kurie, J. M. Dimaio, et al. 2004. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 64: 9027-9034.
23. Kalita, M., B. Tian, B. Gao, S. Choudhary, T. G. Wood, J.R. Carmical, I. Boldogh, S. Mitra, J. D. Minna, and A. R. Brasier. 2013. Systems approaches to modeling chronic mucosal inflammation. BioMed Res. Int. 2013: 505864.
24. Garofalo, R., F. Mei, M. Manganaro, R. Espejo, P. L. Ogra, and V. E. Reyes. Upregulation of class I major histocompatibility complex (MHC) molecules on respiratory syncytial virus (RSV)-infected airway epithelial cells. Am. J. Respir. Crit. Care Med. 1994;149: A987.
25. Reche, P. A., V. Soumelis, D. M. Gorman, T. Clifford, M.-r., M. Liu, S. M. Travis, J. Zurawski, Y.-J. Johnston, H. Liu, Spits, et al. 2001. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J. Immunol. 167: 336-343.
26. Kalita, M. K., K. Sargsyan, B. Tian, A. Paulucci-Holthauzen, H. N. Najm, B. J. Debusschere, and A. R. Brasier. 2011. Sources of cell-to-cell variability in canonical nuclear factor-kB (NF-kB) signaling pathway inferred from single cell dynamic images. J. Biol. Chem. 286: 37741-37757.
27. Brasier, A. R., B. Tian, M. Jamaluddin, M. K. Kalita, R. P. Garofalo, and M. Lu. 2011. RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection. J. Virol. 85: 11752-11769.
28. Wessel, D., and U. I. Flugge. 1984. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138: 141-143.
29. Cox, J., and M. Mann. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26: 1367-1372.
30. Cox, J., M. Y. Hein, C. A. Luber, I. Paron, N. Nagaraj, and M. Mann. 2014. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 13: 2513-2526.
31. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
32. Zybailov, B., A. L. Mosley, M. E. Sardiu, M. K. Coleman, L. Florens, and M. P. Washburn. 2006. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J. Proteome Res. 5: 2339-2347.
33. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102: 15545-15550.
34. Keerthikumar, S., D. Chisanga, D. Ariyaratne, H. Al Saffar, S. Anand, K. Zhao, M. Samuel, M. Pathan, M. Jois, N. Chilamkurti, et al. 2016. ExoCarta: A webbased compendium of exosomal cargo. J. Mol. Biol. 428: 688-692.
35. Zhao, Y., and A. R. Brasier. 2013. Applications of selected reaction monitoring (SRM)-mass spectrometry (MS) for quantitative measurement of signaling pathways. Methods 61: 313-322.
36. Haeberle, H. A., R. Takizawa, A. Casola, A. R. Brasier, H. J. Dieterich, N. Van Rooijen, Z. Gatalica, and R. P. Garofalo. 2002. Respiratory syncytial virusinduced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J. Infect. Dis. 186: 1199-1206.
37. Gao, B., C. Huang, J. P. Sullivan, M. Spinola, M. Gabriela Raso, I. Wistuba, J. Shay, and J. D. Minna. 2009. Immortalization of human small airway epithelial cells with characteristics of bronchioalveolar stem cells. FASEB J. 23 (Suppl.): LB340 (Meeting Abstract).
38. Tian, B., Y. Zhao, M. Kalita, C. B. Edeh, S. Paessler, A. Casola, M. N. Teng, R. P. Garofalo, and A. R. Brasier. 2013. CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells. J. Virol. 87: 7075-7092.
39. Fang, L., S. Choudhary, B. Tian, I. Boldogh, C. Yang, T. Ivanciuc, Y. Ma, R. P. Garofalo, and A. R. Brasier. 2015. Ataxia telangiectasia mutated kinase mediates NF-kB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection. J. Virol. 89: 2628-2642.
40. Zhang, L., M. E. Peeples, R. C. Boucher, P. L. Collins, and R. J. Pickles. 2002. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 76: 5654-5666.
41. Thomas, K. W., M. M. Monick, J. M. Staber, T. Yarovinsky, A. B. Carter, and G. W. Hunninghake. 2002. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 277: 492-501.
42. Liu, H., R. G. Sadygov, and J. R. Yates, III. 2004. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76: 4193-4201.
43. Old, W. M., K. Meyer-Arendt, L. Aveline-Wolf, K. G. Pierce, A. Mendoza, J. R. Sevinsky, K. A. Resing, and N. G. Ahn. 2005. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics 4: 1487-1502.
44. Paoletti, A. C., T. J. Parmely, C. Tomomori-Sato, S. Sato, D. Zhu, R. C. Conaway, J. W. Conaway, L. Florens, and M. P. Washburn. 2006. Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc. Natl. Acad. Sci. USA 103: 18928-18933.
45. Nickel, W., and C. Rabouille. 2009. Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10: 148-155.
46. Zhao, Y., B. Tian, C. B. Edeh, and A. R. Brasier. 2013. Quantitation of the dynamic profiles of the innate immune response using multiplex selected reaction monitoring-mass spectrometry. Mol. Cell. Proteomics 12: 1513-1529.
47. Zhao, Y. X., S. G. Widen, M. Jamaluddin, B. Tian, T. G. Wood, C. B. Edeh, and A. R. Brasier. 2011. Quantification of activated NF-kappa B/RelA complexes using ssDNA aptamer affinity-stable isotope dilution-selected reaction monitoring-mass spectrometry. Mol. Cell. Proteomics 10: M111.008771.
48. Gerber, S. A., J. Rush, O. Stemman, M. W. Kirschner, and S. P. Gygi. 2003. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 100: 6940-6945.
49. Krämer, A., J. Green, J. Pollard, Jr., and S. Tugendreich. 2014. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30: 523-530.
50. Lee, H. C., M. B. Headley, Y. M. Loo, A. Berlin, M. Gale, Jr., J. S. Debley, N. W. Lukacs, and S. F. Ziegler. 2012. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J. Allergy Clin. Immunol. 130(5):1187-1196.e5.
51. Kim, S., C. Lewis, and J. A. Nadel. 2011. CCL20/CCR6 feedback exaggerates epidermal growth factor receptor-dependent MUC5AC mucin production in human airway epithelial (NCI-H292) cells. J. Immunol. 186(6): 3392-3400.
52. Kallal, L. E., M. A. Schaller, D. M. Lindell, S. A. Lira, and N. W. Lukacs. 2010. CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. Eur. J. Immunol. 40: 1042-1052.
53. Hull, J., K. Rowlands, E. Lockhart, C. Moore, M. Sharland, and D. Kwiatkowski. 2003. Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J. Infect. Dis. 188: 904-907.
54. Roy, M. G., A. Livraghi-Butrico, A. A. Fletcher, M. M. McElwee, S. E. Evans, R. M. Boerner, S. N. Alexander, L. K. Bellinghausen, A. S. Song, Y. M. Petrova, et al. 2014. Muc5b is required for airway defence. Nature 505: 412-416.
55. Aherne, W., T. Bird, S. D. Court, P. S. Gardner, and J. McQuillin. 1970. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 23: 7-18.
56. Ferris, J. A., W. A. Aherne, W. S. Locke, J. McQuillin, and P. S. Gardner. 1973. Sudden and unexpected deaths in infants: histology and virology. Br. Med. J. 2: 439-442.
57. Haeberle, H. A., A. Casola, Z. Gatalica, S. Petronella, H. J. Dieterich, P. B. Ernst, A. R. Brasier, and R. P. Garofalo. 2004. IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection. J. Virol. 78: 2232-2241.
58. Bertolusso, R., B. Tian, Y. Zhao, L. Vergara, A. Sabree, M. Iwanaszko, T. Lipniacki, A. R. Brasier, and M. Kimmel. 2014. Dynamic cross talk model of the epithelial innate immune response to double-stranded RNA stimulation: coordinated dynamics emerging from cell-level noise. [Published erratum appears in 2014 PLoS One 9: e103019.] PLoS One 9: e93396.
59. Jamaluddin, M., S. Wang, R. P. Garofalo, T. Elliott, A. Casola, S. Baron, and A. R. Brasier. 2001. IFN-beta mediates coordinate expression of antigenprocessing genes in RSV-infected pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L248-L257.
60. Bao, X., T. Liu, Y. Shan, K. Li, R. P. Garofalo, and A. Casola. 2008. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog. 4: e1000077.
61. Bao, X., T. Liu, L. Spetch, D. Kolli, R. P. Garofalo, and A. Casola. 2007. Airway epithelial cell response to human metapneumovirus infection. Virology 368: 91-101.
62. Knight, D. A., and S. T. Holgate. 2003. The airway epithelium: structural and functional properties in health and disease. Respirology 8: 432-446.
63. Brasier, A. R., H. Spratt, Z. Wu, I. Boldogh, Y. Zhang, R. P. Garofalo, A. Casola, J. Pashmi, A. Haag, B. Luxon, and A. Kurosky. 2004. Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J. Virol. 78: 11461-11476.
64. Munday, D. C., E. Emmott, R. Surtees, C. H. Lardeau, W. Wu, W. P. Duprex, B. K. Dove, J. N. Barr, and J. A. Hiscox. 2010. Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Mol. Cell. Proteomics 9: 2438-2459.
65. Ternette, N., C. Wright, H. B. Kramer, M. Altun, and B. M. Kessler. 2011. Labelfree quantitative proteomics reveals regulation of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) and 59-39-exoribonuclease 2 (XRN2) during respiratory syncytial virus infection. Virol. J. 8: 442.
66. Persson, B. D., A. B. Jaffe, R. Fearns, and H. Danahay. 2014. Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation. PLoS One 9: e102368.
67. Meissner, F., R. A. Scheltema, H.-J. Mollenkopf, and M. Mann. 2013. Direct proteomic quantification of the secretome of activated immune cells. Science 340: 475-478.
68. Théry, C., L. Zitvogel, and S. Amigorena. 2002. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2: 569-579.
69. Levänen, B., N. R. Bhakta, P. Torregrosa Paredes, R. Barbeau, S. Hiltbrunner, J. L. Pollack, C. M. Sköld, M. Svartengren, J. Grunewald, S. Gabrielsson, et al. 2013. Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. J. Allergy Clin. Immunol. 131: 894-903.
70. Torregrosa Paredes, P., J. Esser, C. Admyre, M. Nord, Q. K. Rahman, A. Lukic, O. Radmark, R. Grönneberg, J. Grunewald, A. Eklund, et al. 2012. Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy 67: 911-919.
71. Kesimer, M., M. Scull, B. Brighton, G. DeMaria, K. Burns, W. O'Neal, R. J. Pickles, and J. K. Sheehan. 2009. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: A possible role in innate defense. FASEB J. 23: 1858-1868.
72. Kulshreshtha, A., T. Ahmad, A. Agrawal, and B. Ghosh. 2013. Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation. J. Allergy Clin. Immunol. 131(4):1194-1203.e14.
73. Komiya, Y., and R. Habas. 2008. Wnt signal transduction pathways. Organogenesis 4: 68-75.
74. Sigurs, N., F. Aljassim, B. Kjellman, P. D. Robinson, F. Sigurbergsson, R. Bjarnason, and P. M. Gustafsson. 2010. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65: 1045-1052.
75. Sigurs, N., R. Bjarnason, and F. Sigurbergsson. 1994. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Pediatr. 83: 1151-1155.
76. Allakhverdi, Z., M. R. Comeau, H. K. Jessup, B. R. Yoon, A. Brewer, S. Chartier, N. Paquette, S. F. Ziegler, M. Sarfati, and G. Delespesse. 2007. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 204: 253-258.
77. Ziegler, S. F., F. Roan, B. D. Bell, T. A. Stoklasek, M. Kitajima, and H. Han. 2013. The biology of thymic stromal lymphopoietin (TSLP). Adv Pharmacol. 66: 129-155.
78. Yamazaki, T., X. O. Yang, Y. Chung, A. Fukunaga, R. Nurieva, B. Pappu, N. Martin-Orozco, H. S. Kang, L. Ma, A. D. Panopoulos, et al. 2008. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181 (12): 8391-8401.
79. Mangodt, T. C., M. A. Van Herck, S. Nullens, J. Ramet, J. J. De Dooy, P. G. Jorens, and B. Y. De Winter. 2015. The role of Th17 and Treg responses in the pathogenesis of RSV infection. Pediatr. Res. 78: 483-491.
80. Hashimoto, K., B. S. Graham, S. B. Ho, K. B. Adler, R. D. Collins, S. J. Olson, W. Zhou, T. Suzutani, P. W. Jones, K. Goleniewska, et al. 2004. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am. J. Respir. Crit. Care Med. 170: 306-312.
81. Moore, M. L., M. H. Chi, C. Luongo, N. W. Lukacs, V. V. Polosukhin, M. M. Huckabee, D. C. Newcomb, U. J. Buchholz, J. E. Crowe, Jr., K. Goleniewska, et al. 2009. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J. Virol. 83: 4185-4194.